Global Plasma Fractionation Market by Product (Albumin, Immunoglobulins, and Coagulation Factor VIII), Application (Neurology, Hematology, Immunology, Critical Care and Others), End User (Hospitals, and Research Laboratories): Global Opportunity Analysis and Industry Forecast, 2018–2028
- ALL3414457
- 205 Pages
- November 2019
- Healthcare
Fractionation is a mechanical process carried out to separate a certain quantity of mixture. Plasma is the liquid part of the blood which is yellowish and holds blood cells. Plasma fractionation is carried out to separate high quality, proteinaceous products such as albumin, immunoglobulins, and others. These derived products are known as plasma derivatives obtained from fractionation. Moreover, these products are used in various medical fields such as in neurology, hematology, critical care, immunology, and others. For instance, in critical care, plasma is prescribed to prevent and stop bleeding. In addition, plasma products are widely used in clinical research laboratories and hospitals.
The factors that boost the growth of the plasma fractionation market include surge in geriatric population across the globe, which is predisposed to various rare diseases that require the use of plasma derivatives. Moreover, rise in use of immunoglobulins and alpha-1-antitrypsin in areas of medicine worldwide also fuel the growth of the plasma fractionation market. Furthermore, surge in plasma collection centers worldwide is another major factor that contributes toward the growth of this market.
In addition, favorable governmental support to spread awareness related to the use of plasma derived products also fuels the growth of the plasma fractionation market. However, high cost of plasma derived products restricts the growth of the market. Conversely, growth potential in emerging economies is expected to create lucrative opportunities for the market growth during the forecast period.
The global plasma fractionation market is segmented on the basis of product, application, end user, and region. On the basis of product, the market is divided into albumin, immunoglobulins, and coagulation factor VIII. Moreover, immunoglobulins are further divided into subcutaneous immunoglobulin (SCIG) and coagulation factor VIII. By application, the market is classified into neurology, hematology, immunology, critical care, and others. On the basis of end user, it is categorized into hospitals and clinical research laboratories. By country, it is analyzed across Russia, Kazakhstan, Indonesia, China (Including Taiwan), India, Saudi Arabia, Egypt, Vietnam, Argentina, Thailand, and Nigeria.
KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global plasma fractionation market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
• By Product
o Albumin
o Immunoglobulins
o Subcutaneous Immunoglobulin (SCIG)
o Intravenous Immunoglobulin (IVIG)
o Coagulation Factor
• By Application
o Neurology
o Hematology
o Immunology
o Critical Care
o Others
• By End User
o Hospitals
o Clinical Research Laboratories
• By Country
o Russia
o Kazakhstan
o Indonesia
o China (Including Taiwan)
o India
o Saudi Arabia
o Egypt
o Vietnam
o Argentina
o Thailand
o Nigeria
o Rest of the World
List of key players profiled in the report:
• Grifols SA
• Baxter International Inc
• CSL LTD.
• Bio Product Laboratory
• Octapharma AG
• Sanquin
• Laboratoire Franais Du Fractionnement Et Des
• Kedrion
• Biotest
• Takeda Pharmaceuticals
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• LFB S.A.
• Shanghai RAAS Blood Products Co., Ltd.
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List Of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings Of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.3. Porter'S Five Forces Analysis
3.3.1. Bargaining Power Of Buyers
3.3.2. Bargaining Power Of Suppliers
3.3.3. Thereat Of New Entrants
3.3.4. Threat Of Substitutes
3.3.5. Intensity Of Competitive Rivalry
3.4. Top Player Positioning, 2018
3.5. Market Dynamics
3.5.1. Drivers
3.5.1.1. Surge In Geriatric Population Across The Globe Coupled With Rise In Prevalence Of Rare Diseases
3.5.1.2. Rise In Use Of Immunoglobulins In Areas Of Medicine
3.5.1.3. Increase In Number Of Plasma Collection Centers Across The Globe
3.5.2. Restraint
3.5.2.1. High Cost Of Plasma Derived Products
3.5.3. Opportunity
3.5.3.1. High Growth Potential In Emerging Economies
3.5.4. Impact Analysis
Chapter 4: Plasma Fractionation Market, By Product
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Albumin
4.2.1. Key Market Trends And Growth Opportunities
4.2.2. Market Size And Forecast, By Country
4.3. Immunoglobulins
4.3.1. Key Market Trends And Growth Opportunities
4.3.2. Market Size And Forecast, By Type
4.3.2.1. Subcutaneous Immunoglobulin
4.3.2.1.1. Market Size And Forecast
4.3.2.2. Intravenous Immunoglobulin
4.3.2.2.1. Market Size And Forecast
4.3.3. Market Size And Forecast, By Country
4.4. Coagulation Factor Viii
4.4.1. Key Market Trends And Growth Opportunities
4.4.2. Market Size And Forecast, By Country
Chapter 5: Plasma Fractionation Market, By Application
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Neurology
5.2.1. Market Size And Forecast, By Region
5.3. Hematology
5.3.1. Market Size And Forecast, By Region
5.4. Immunology
5.4.1. Market Size And Forecast, By Region
5.5. Critical Care
5.5.1. Market Size And Forecast, By Region
5.6. Others
5.6.1. Market Size And Forecast, By Region
Chapter 6: Plasma Fractionation Market, By End User
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Hospitals
6.2.1. Market Size And Forecast, By Region
6.3. Clinical Research Laboratories
6.3.1. Market Size And Forecast, By Region
Chapter 7: Plasma Fractionation Market, By Country
7.1. Overview
7.1.1. Market Size And Forecast
7.2. Russia
7.2.1. Key Market Trends And Growth Opportunities
7.2.2. Market Size And Forecast, By Product
7.2.3. Market Size And Forecast, By Application
7.2.4. Market Size And Forecast, By End User
7.3. Kazakhstan
7.3.1. Key Market Trends And Growth Opportunities
7.3.2. Market Size And Forecast, By Product
7.3.3. Market Size And Forecast, By Application
7.3.4. Market Size And Forecast, By End User
7.4. Indonesia
7.4.1. Key Market Trends And Growth Opportunities
7.4.2. Market Size And Forecast, By Product
7.4.3. Market Size And Forecast, By Application
7.4.4. Market Size And Forecast, By End User
7.5. China (Including Taiwan)
7.5.1. Key Market Trends And Growth Opportunities
7.5.2. Market Size And Forecast, By Product
7.5.3. Market Size And Forecast, By Application
7.5.4. Market Size And Forecast, By End User
7.6. India
7.6.1. Key Market Trends And Growth Opportunities
7.6.2. Market Size And Forecast, By Product
7.6.3. Market Size And Forecast, By Application
7.6.4. Market Size And Forecast, By End User
7.7. Saudi Arabia
7.7.1. Key Market Trends And Growth Opportunities
7.7.2. Market Size And Forecast, By Product
7.7.3. Market Size And Forecast, By Application
7.7.4. Market Size And Forecast, By End User
7.8. Egypt
7.8.1. Key Market Trends And Growth Opportunities
7.8.2. Market Size And Forecast, By Product
7.8.3. Market Size And Forecast, By Application
7.8.4. Market Size And Forecast, By End User
7.9. Vietnam
7.9.1. Key Market Trends And Growth Opportunities
7.9.2. Market Size And Forecast, By Product
7.9.3. Market Size And Forecast, By Application
7.9.4. Market Size And Forecast, By End User
7.10. Argentina
7.10.1. Key Market Trends And Growth Opportunities
7.10.2. Market Size And Forecast, By Product
7.10.3. Market Size And Forecast, By Application
7.10.4. Market Size And Forecast, By End User
7.11. Thailand
7.11.1. Key Market Trends And Growth Opportunities
7.11.2. Market Size And Forecast, By Product
7.11.3. Market Size And Forecast, By Application
7.11.4. Market Size And Forecast, By End User
7.12. Nigeria
7.12.1. Key Market Trends And Growth Opportunities
7.12.2. Market Size And Forecast, By Product
7.12.3. Market Size And Forecast, By Application
7.12.4. Market Size And Forecast, By End User
7.13. Rest Of The World
7.13.1. Key Market Trends And Growth Opportunities
7.13.2. Market Size And Forecast, By Product
7.13.3. Market Size And Forecast, By Application
7.13.4. Market Size And Forecast, By End User
Chapter 8: Company Profiles
8.1. Baxter International Inc.
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Business Performance
8.2. Bio Products Laboratory
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.3. Biotest Ag
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.3.5. Business Performance
8.3.6. Key Strategic Moves And Developments
8.4. Csl Ltd.
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.4.5. Business Performance
8.5. Grifols Sa
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Product Portfolio
8.5.5. Business Performance
8.6. Kedrion Biopharma
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.6.5. Business Performance
8.7. Lfb S. A
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.7.5. Business Performance
8.8. Octapharma
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.9. Sanquin Blood Supply Foundation
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Takeda Pharmaceutical Company Limited
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
8.10.6. Key Strategic Moves And Developments
Table 01. Global Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 02. Global Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 03. Plasma Fractionation Market For Albumin, By Country, 2016–2028 ($Million)
Table 04. Plasma Fractionation Market For Albumin, By Country, 2016–2028 (Metric Tons)
Table 05. Plasma Fractionation Market For Immunoglobulins, By Type, 2016–2028 ($Million)
Table 06. Plasma Fractionation Market For Immunoglobulins, By Type, 2016–2028 ($Million)
Table 07. Plasma Fractionation Market For Immunoglobulins, By Country, 2016–2028 ($Million)
Table 08. Plasma Fractionation Market For Immunoglobulins, By Country, 2016–2028 (Metric Tons)
Table 09. Plasma Fractionation Market For Coagulation Factor Viii, By Country, 2016–2028 ($Million)
Table 10. Plasma Fractionation Market For Coagulation Factor Viii, By Country, 2016–2028 (Million International Unit)
Table 11. Global Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 12. Global Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 13. Plasma Fractionation Market For Neurology, By Country, 2016–2028 ($Million)
Table 14. Plasma Fractionation Market For Neurology, By Country, 2016–2028 (Metric Tons)
Table 15. Plasma Fractionation Market For Hematology, By Country, 2016–2028 ($Million)
Table 16. Plasma Fractionation Market For Hematology, By Country, 2016–2028 (Metric Tons)
Table 17. Plasma Fractionation Market For Immunology, By Country, 2016–2028 ($Million)
Table 18. Plasma Fractionation Market For Immunology, By Country, 2016–2028 (Metric Tons)
Table 19. Plasma Fractionation Market For Critical Care, By Country, 2016–2028 ($Million)
Table 20. Plasma Fractionation Market For Critical Care, By Country, 2016–2028 (Metric Tons)
Table 21. Plasma Fractionation Market For Others, By Country, 2016–2028 ($Million)
Table 22. Plasma Fractionation Market For Others, By Country, 2016–2028 (Metric Tons)
Table 23. Global Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 24. Global Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons )
Table 25. Plasma Fractionation Market For Hospitals, By Country, 2016–2028 ($Million)
Table 26. Plasma Fractionation Market For Hospitals, By Country, 2016–2028 (Metric Tons )
Table 27. Plasma Fractionation Market For Clinical Research Laboratories, By Country, 2016–2028 ($Million)
Table 28. Plasma Fractionation Market For Clinical Research Laboratories, By Country, 2016–2028 (Metric Tons )
Table 29. Global Plasma Fractionation Market, By Country, 2016–2028 ($Million)
Table 30. Global Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 31. Russia Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 32. Russia Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 33. Russia Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 34. Russia Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 35. Russia Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 36. Russia Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 37. Kazakhstan Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 38. Kazakhstan Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 39. Kazakhstan Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 40. Kazakhstan Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 41. Kazakhstan Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 42. Kazakhstan Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 43. Indonesia Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 44. Indonesia Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 45. Indonesia Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 46. Indonesia Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 47. Indonesia Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 48. Indonesia Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 49. China Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 50. China Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 51. China Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 52. China Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 53. China Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 54. China Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 55. India Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 56. India Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 57. India Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 58. India Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 59. India Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 60. India Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 61. Saudi Arabia Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 62. Saudi Arabia Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 63. Saudi Arabia Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 64. Saudi Arabia Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 65. Saudi Arabia Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 66. Saudi Arabia Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 67. Egypt Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 68. Egypt Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 69. Egypt Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 70. Egypt Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 71. Egypt Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 72. Egypt Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 73. Vietnam Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 74. Vietnam Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 75. Vietnam Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 76. Vietnam Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 77. Vietnam Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 78. Vietnam Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 79. Argentina Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 80. Argentina Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 81. Argentina Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 82. Argentina Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 83. Argentina Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 84. Argentina Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 85. Thailand Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 86. Thailand Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 87. Thailand Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 88. Thailand Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 89. Thailand Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 90. Thailand Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 91. Nigeria Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 92. Nigeria Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 93. Nigeria Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 94. Nigeria Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 95. Nigeria Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 96. Nigeria Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 97. Rest of The World Plasma Fractionation Market, By Product, 2016–2028 ($Million)
Table 98. Rest of The World Plasma Fractionation Market, By Product, 2016–2028 (Metric Tons)
Table 99. Rest of The World Plasma Fractionation Market, By Application, 2016–2028 ($Million)
Table 100. Rest of The World Plasma Fractionation Market, By Application, 2016–2028 (Metric Tons)
Table 101. Rest of The World Plasma Fractionation Market, By End User, 2016–2028 ($Million)
Table 102. Rest of The World Plasma Fractionation Market, By End User, 2016–2028 (Metric Tons)
Table 103. Baxter: Company Snapshot
Table 104. Baxter: Product Segment
Table 105. Baxter: Product Portfolio
Table 106. Bio Products Laboratory: Company Snapshot
Table 107. Bio Products Laboratory: Operating Segments
Table 108. Bio Products Laboratory: Product Portfolio
Table 109. Biotest Ag: Company Snapshot
Table 110. Biotest Ag: Operating Segments
Table 111. Biotest Ag: Product Portfolio
Table 112. Csl Ltd..: Company Snapshot
Table 113. Csl Ltd..: Operating Segment
Table 114. Csl Ltd..: Product Portfolio
Table 115. Grifols Sa: Company Snapshot
Table 116. Grifols Sa: Operating Segments
Table 117. Grifols Sa: Product Portfolio
Table 118. Kedrion: Company Snapshot
Table 119. Kedrion: Operating Segments
Table 120. Kedrion: Product Portfolio
Table 121. Lfb S.A: Company Snapshot
Table 122. Lfb S.A: Operating Segments
Table 123. Lfb S.A: Product Portfolio
Table 124. Octapharma: Company Snapshot
Table 125. Octapharma: Operating Segments
Table 126. Octapharma: Product Portfolio
Table 127. Sanquin Blood Supply Foundation: Company Snapshot
Table 128. Sanquin Blood Supply Foundation: Operating Segments
Table 129. Sanquin Blood Supply Foundation: Product Portfolio
Table 130. Takeda: Company Snapshot
Table 131. Takeda: Product Portfolio
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
